Table 5:

Indications of PTRA in patients with ARVD.

Strong indications

• High-grade (>70%) RAS in association with one of the following criteria:• Resistant hypertension• New-onset or recently uncontrolled hypertension• Acute pulmonary oedema or acute decompensated HF• Rapid decline of eGFR (bilateral stenosis or solitary kidney)• ACEI or ARB intolerance (≥30% eGFR reduction)• Renal replacement treatment (with possibly viable renal parenchyma) if stenosis detected <3 months after renal replacement treatment or if uncontrolled hypertension with multiple (five or more) antihypertensive agents• AKI due to acute renal artery occlusion or high-grade stenosis• Kidney transplant with RAS

Moderately strong indications

• High-grade (>70%) RAS in association with one of the following criteria:• Chronic HF• Asymptomatic but either bilateral or supplying a solitary kidney with viable renal parenchyma (non-atrophic kidney, distinct renal cortex)